OPEC Rumors of a June Output Increase, Ceilings Hold for Brent and WTI Walsh Trading - 1 hour ago The June WTI (CLM25 ) contract settled at 62.79 (+0.52) [+0.84%] , high of 63.31, low of 61.99. Spot price is 62.24 (-1.44). Open interest for CLM25 is 300,434. CLM25 settled below its 5 day (63.02), below...
Dollar Weakness and Stock Gains Lift Crude Prices Barchart - Thu Apr 24, 2:21PM CDT June WTI crude oil (CLM25 ) Thursday closed up +0.52 (+0.84%), and June RBOB gasoline (RBM25 ) closed up +0.0220 (+1.06%). Crude oil and gasoline prices on Thursday posted moderate gains. Thursday's weaker...
Nat-Gas Prices Tumble as Weekly EIA Inventories Jump Barchart - Thu Apr 24, 2:20PM CDT May Nymex natural gas (NGK25 ) on Thursday closed down by -0.092 (-3.04%). May nat-gas prices on Thursday tumbled to a 5-month nearest-futures low and settled sharply lower on a larger-than-expected build...
This Under-the-Radar Energy Stock Is Heating Up Barchart - Thu Apr 24, 1:05PM CDT Atmos Energy Corporation (ATO) is a regulated natural gas distributor with a strong focus on modernizing its network and reducing regulatory lag. ATO has a 100% technical “buy” signal and is trading...
Crude Moderately Higher on Dollar Weakness and Stock Gains Barchart - Thu Apr 24, 10:39AM CDT June WTI crude oil (CLM25 ) today is up +0.21 (+0.34%), and June RBOB gasoline (RBM25) is up +0.0069 (+0.33%). Crude oil and gasoline prices today are moderately higher. Today's weaker dollar (DXY00 )...
WTI Futures Rebound Off Support as OPEC Response Looms Blue Line Futures - Thu Apr 24, 9:04AM CDT WTI Crude Oil futures fell yesterday on trade relations and news regarding OPEC. Kazakhstan came out yesterday and said that their oil production was out of their control, dashing hopes they would be willing...
Marathon Petroleum's Quarterly Earnings Preview: What You Need to Know Barchart - Thu Apr 24, 6:16AM CDT Marathon Petroleum is expected to release its fiscal first-quarter earnings next month, and analysts project a triple-digit earnings fall.
Crude Prices Fall on Fears of Global Oversupply Barchart - Wed Apr 23, 2:38PM CDT June WTI crude oil (CLM25 ) Wednesday closed down -1.40 (-2.20%), and June RBOB gasoline (RBM25 ) closed down -0.0165 (-0.79%). Crude oil and gasoline prices on Wednesday fell back from 2-1/2 week highs...
Forecasts for Cooler US Temps Boost Nat-Gas Prices Barchart - Wed Apr 23, 2:37PM CDT May Nymex natural gas (NGK25 ) on Wednesday closed up by +0.015 (+0.50%). May nat-gas prices posted moderate gains on Wednesday as forecasts for cooler US temperatures sparked some short-covering in nat-gas...
Crude hits rare resistance—Kazakhstan rattles OPEC+ expectations. Blue Line Futures - Wed Apr 23, 11:08AM CDT WTI Crude Oil futures rallied yesterday after Scott Bessent’s positive comments regarding trade relations with China and President Trump’s more hawkish Iran comments.
Generation Bio Reports Business Highlights and Third Quarter 2021 Financial Results Globe Newswire - Wed Nov 10, 2021 New preclinical retinal data illustrating potential for expansive therapeutic applications of ctLNP delivery presented at ESGCT 2021 Annual Virtual...
Generation Bio to Present at Jefferies Virtual Gene Therapy/Editing Summit Globe Newswire - Thu Oct 21, 2021 CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...
Generation Bio to Present at European Society of Gene and Cell Therapy 2021 Annual Virtual Congress Globe Newswire - Fri Oct 15, 2021 CAMBRIDGE, Mass., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...
Generation Bio Reports Business Highlights and Second Quarter 2021 Financial Results Globe NewsWire - Wed Aug 11, 2021 CAMBRIDGE, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co . (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported...
Generation Bio to Present at Wedbush PacGrow Healthcare Conference 2021 Globe NewsWire - Tue Aug 3, 2021 CAMBRIDGE, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced...
Generation Bio Announces Plan to Scale Next-Generation Rapid Enzymatic Manufacturing Process Across Portfolio and Provides Pipeline Update Globe NewsWire - Wed Jul 14, 2021 Company to transition all portfolio programs to rapid enzymatic synthesis (RES), enabling improved quality, scale and speed of closed-ended DNA manufacturing
Generation Bio to Present at William Blair Biotech Focus Conference Globe NewsWire - Thu Jul 8, 2021 CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff...
Generation Bio to Present at the JMP Securities Life Sciences Conference Globe NewsWire - Wed Jun 9, 2021 CAMBRIDGE, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff...
Generation Bio to Present at the Jefferies Virtual Healthcare Conference Globe NewsWire - Thu May 27, 2021 CAMBRIDGE, Mass., May 27, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff...
Generation Bio Reports Business Highlights and Third Quarter 2021 Financial Results Globe Newswire - Wed Nov 10, 2021 New preclinical retinal data illustrating potential for expansive therapeutic applications of ctLNP delivery presented at ESGCT 2021 Annual Virtual...
Generation Bio to Present at Jefferies Virtual Gene Therapy/Editing Summit Globe Newswire - Thu Oct 21, 2021 CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...
Generation Bio to Present at European Society of Gene and Cell Therapy 2021 Annual Virtual Congress Globe Newswire - Fri Oct 15, 2021 CAMBRIDGE, Mass., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...
Generation Bio Reports Business Highlights and Second Quarter 2021 Financial Results Globe NewsWire - Wed Aug 11, 2021 CAMBRIDGE, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co . (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported...
Generation Bio to Present at Wedbush PacGrow Healthcare Conference 2021 Globe NewsWire - Tue Aug 3, 2021 CAMBRIDGE, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced...
Generation Bio Announces Plan to Scale Next-Generation Rapid Enzymatic Manufacturing Process Across Portfolio and Provides Pipeline Update Globe NewsWire - Wed Jul 14, 2021 Company to transition all portfolio programs to rapid enzymatic synthesis (RES), enabling improved quality, scale and speed of closed-ended DNA manufacturing
Generation Bio to Present at William Blair Biotech Focus Conference Globe NewsWire - Thu Jul 8, 2021 CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff...
Generation Bio to Present at the JMP Securities Life Sciences Conference Globe NewsWire - Wed Jun 9, 2021 CAMBRIDGE, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff...
Generation Bio to Present at the Jefferies Virtual Healthcare Conference Globe NewsWire - Thu May 27, 2021 CAMBRIDGE, Mass., May 27, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff...
Generation Bio Reports Business Highlights and Third Quarter 2021 Financial Results Globe Newswire - Wed Nov 10, 2021 New preclinical retinal data illustrating potential for expansive therapeutic applications of ctLNP delivery presented at ESGCT 2021 Annual Virtual...
Generation Bio to Present at Jefferies Virtual Gene Therapy/Editing Summit Globe Newswire - Thu Oct 21, 2021 CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...
Generation Bio to Present at European Society of Gene and Cell Therapy 2021 Annual Virtual Congress Globe Newswire - Fri Oct 15, 2021 CAMBRIDGE, Mass., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people...
Generation Bio Reports Business Highlights and Second Quarter 2021 Financial Results Globe NewsWire - Wed Aug 11, 2021 CAMBRIDGE, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co . (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported...
Generation Bio to Present at Wedbush PacGrow Healthcare Conference 2021 Globe NewsWire - Tue Aug 3, 2021 CAMBRIDGE, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced...
Generation Bio Announces Plan to Scale Next-Generation Rapid Enzymatic Manufacturing Process Across Portfolio and Provides Pipeline Update Globe NewsWire - Wed Jul 14, 2021 Company to transition all portfolio programs to rapid enzymatic synthesis (RES), enabling improved quality, scale and speed of closed-ended DNA manufacturing
Generation Bio to Present at William Blair Biotech Focus Conference Globe NewsWire - Thu Jul 8, 2021 CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff...
Generation Bio to Present at the JMP Securities Life Sciences Conference Globe NewsWire - Wed Jun 9, 2021 CAMBRIDGE, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff...
Generation Bio to Present at the Jefferies Virtual Healthcare Conference Globe NewsWire - Thu May 27, 2021 CAMBRIDGE, Mass., May 27, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff...